Abstract
Switzerland has a very wealthy and sophisticated healthcare market. This
report is ideal for executives wanting to understand the key drivers in the
medical market and have access to a wealth of statistical data, including
five-year market projections. Included with the report are 3 free quarterly
updated outlook reports, enabling you to keep up to date with market
developments for a year.
Includes 3 quarterly updated outlook reports!
Switzerland is a major medical device manufacturer which has, over a period of
years, aligned its regulatory requirements to those of the European Union.
Success in the Swiss market depends on meeting the high standards expected by
the end-users who look for quality, durability, service, ease of operation and
time-saving features. These requirements have led to Swiss manufacturers being
at the forefront of medical device development.
The five university medical centres maintain an international reputation and
are well equipped. Cantonal, municipal and private hospitals tend to follow
the lead of university hospitals when buying equipment. Major equipment
purchases by state hospitals must be approved by the cantonal or municipal
authorities.
In practice, technology involving new forms of patient treatment, as well as
requiring technical approval, needs to be approved by the health insurance
funds in order to qualify for reimbursement. Such decisions are undertaken by
a multi-disciplinary committee at federal level and become mandatory for all
cantons, the fee for the new service being fixed by a supracantonal body.
The private sector, although only accounting for 15%-20% of the total medical
market, can be an important end-user of expensive capital equipment, due to
the absence of any purchasing restrictions on private facilities. For example,
an estimated 60% of MRI units are to be found in the private sector.